Pluricell Biotech
Campinas
About Pluricell Biotech
PluriCell wants to positively impact the lives of millions of patients suffering from chronic heart failure condition by injecting healthy bona fide lab-made human heart cells in their failing heart and improving its function and the clinical outcome of the patients.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.0M
- Funding stage: Seed
- Last round: Seed (Jun 2019)
- Website: pluricellbiotech.com.brhome
Industries & Categories
CRM, Health Care, Information Technology
Canonical: https://fsome.com/organization/pluricell-biotech-161057 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.